Litcius/Paper detail

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Tushar D. Nichakawade, Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang, Sarah R. DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian F. Konig, Sandra B. Gabelli, Evangeline Watson, Cole Sterling, Nina D. Wagner‐Johnston, Sima Rozati, Lode J. Swinnen, Ephraim J. Fuchs, Drew M. Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W. Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul

2024Nature44 citationsDOIOpen Access PDF

Topics & Concepts

Chimeric antigen receptorAntibodyMedicineAntibody-drug conjugateCancer researchCancerT cellImmunologyCellAntigenImmunotherapyMonoclonal antibodyInternal medicineBiologyImmune systemGeneticsCAR-T cell therapy researchCutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers | Litcius